Table 3

Diabetic Peripheral Neuropathy Symptom Scores, change analysis comparing baseline to 6 months for placebo and supplement groups (Fisher's exact test p=0.0024)

One-point decrease (improvement)No changeOne-point increase (worsening)
DPNSS change for placebo group1 subject (3.6%)23 subjects (82.1%)4 subjects (14.2%)
DPNSS change for DiVFuSS group13 subjects (33.3%)25 subject (64.1%)1 subject (2.6%)
  • DiVFuSS, Diabetes Visual Function Supplement Study; DPNSS, Diabetic Peripheral Neuropathy Symptom Score.